These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work? Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600 [TBL] [Abstract][Full Text] [Related]
4. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ; Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088 [TBL] [Abstract][Full Text] [Related]
7. [Extracorporeal photochemotherapy: review of its mechanisms of action and clinical applications]. Vanheste S; Vereecken P; Lambermont M; Heenen M; Bron D Rev Med Brux; 2007; 28(5):445-51. PubMed ID: 18069519 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. Fimiani M; Di Renzo M; Rubegni P Br J Dermatol; 2004 Jun; 150(6):1055-60. PubMed ID: 15214889 [TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis: Lighting the way to immunomodulation. Babic AM Am J Hematol; 2008 Jul; 83(7):589-91. PubMed ID: 18335565 [TBL] [Abstract][Full Text] [Related]
10. Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis. French LE; Alcindor T; Shapiro M; McGinnis KS; Margolis DJ; Porter D; Leonard DG; Rook AH; Foss F Bone Marrow Transplant; 2002 Oct; 30(8):509-15. PubMed ID: 12379890 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells. Rao V; Saunes M; Jørstad S; Moen T Clin Immunol; 2009 Dec; 133(3):303-13. PubMed ID: 19773201 [TBL] [Abstract][Full Text] [Related]
12. Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of 3 cases. Schreiner T; Gaczkowski A; Scharffetter-Kochanek K; Borberg H Transfus Apher Sci; 2005 Apr; 32(2):197-203. PubMed ID: 15784454 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease. Two indications for photopheresis in dermatology. Girardi M; Heald PW Dermatol Clin; 2000 Jul; 18(3):417-23, viii. PubMed ID: 10943537 [TBL] [Abstract][Full Text] [Related]
17. UV treatment of chronic skin graft-versus-host disease--focus on UVA1 and extracorporeal photopheresis. Greinix HT; Tanew A Curr Probl Dermatol; 2012; 43():116-31. PubMed ID: 22377925 [TBL] [Abstract][Full Text] [Related]
18. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Spisek R; Gasova Z; Bartunkova J Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731 [TBL] [Abstract][Full Text] [Related]
19. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas. Atta M; Papanicolaou N; Tsirigotis P Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605 [TBL] [Abstract][Full Text] [Related]